Denali Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Denali Therapeutics Inc 's ROA in the second quarter of 2026?
Denali Therapeutics Inc achieved a return on average assets (ROA) of 0.09 % in its second quarter of 2026, this is above DNLI's average return on assets of -6.3%.
Denali Therapeutics Inc assets over the 12 months ending in its second quarter of 2026 are valued at $1,151 million

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 211 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2464, from total ROA ranking in the first quarter of 2026 at 2934.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	0.97 %	1.1 %	-15.39 %	-27.64 %	-22.48 %
Y / Y Net Income Change	-	-	24.66 %	-	-
Net Income (TTM) in million	1	4	0	-76	-56
Return On Assets (TTM)	0.09 %	0.38 %	-0.01 %	-6.35 %	-4.35 %
DNLI's Total Ranking	# 2464	# 2934	# 3108	# 2984	# 2864
Total Assets (TTM) in million	1,158	1,266	1,145	1,037	1,147
Seq. Total Assets Change	-8.54 %	10.58 %	10.4 %	-9.58 %	-8.41 %
Seq. Net Income Change	-	-	-	-	-

DNLI's 5 Years Annual ROA >> Back to DNLI Management Effectiveness >> Compare DNLI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 23
Sector	# 212
Overall	# 2512

Return On Assets Statistics
High	Average	Low
24.4 %	-6.3 %	-34.23 %
(Sep 30 2023)		(Dec 31 2021)

Financial Statements
Denali Therapeutics Inc 's Assets	$ 1,158 million	DNLI's Balance sheet
Denali Therapeutics Inc 's Income	$ -128 million	Quarterly DNLI's Income Statement
DNLI's Income by Division		See DNLI's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-8.12 %	19.98 %	-21.16 %	3.99 %	-12.62 %
Total Assets in million	1,243	1,353	1,128	1,430	1,376
Y / Y Net Income Change	-	-	-	-	-99.6 %
Net Income in million	0	0	0	0	1
Annual Return On Assets	-0.01 %	-0.01 %	-0 %	-0 %	0.04 %

DNLI's 5 Years Annual ROA >> Back to DNLI Management Effectiveness >> Compare DNLI ROA to its Competitors

More Return On Assets Ratios
DNLI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DNLI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DNLI's Competitors
Subscribers only: Roa for Denali Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for DNLI's Customers

You may also want to know
DNLI's Roi	DNLI's Inventory Turnover Ratio	DNLI's Growth Rates	DNLI's Dividend Comparisons
	DNLI's Profitability Ratios	DNLI's Asset Turnover Ratio	DNLI's Dividend Growth
DNLI's Roe	DNLI's Valuation Ratios	DNLI's Financial Strength Ratios	DNLI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Talkspace Inc	0.14 %
Champions Oncology Inc	0.13 %
Denali Therapeutics Inc	0.09 %

Date modified: 2026-09-06T12:18:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.